Position in CRBU
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$804,199
+$131,211 QoQ
Shares Held
423,263
0.0% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 137 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 69.2507967859227.ToString("F0")%
Shared 0.ToString("F0")%
None 30.749203214077298.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. CRBU ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in CRBU
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $804,199 | 423,263 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $672,988 | 423,263 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $899,992 | 386,263 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $451,285 | 358,163 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,498,398 | 1,641,181 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,635,521 | 1,657,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,171,756 | 1,618,243 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,649,549 | 1,615,579 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,625,229 | 6,347,321 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $29,335,686 | 5,119,666 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $25,589,199 | 5,353,389 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,548,120 | 1,070,146 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,816,600 | 3,355,292 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,089,048 | 3,198,893 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $25,272,208 | 2,395,470 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,330,968 | 797,600 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,820,941 | 743,022 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,231,385 | 412,948 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,769,269 | 283,589 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||